Cargando…
Sorting Out the Risks and Benefits of the #797 Recommended Intrapartum Vancomycin Dosing Approach
ACOG Committee Opinion #797 proposed intrapartum vancomycin dosing guidelines in the absence of thorough evaluation of its risk versus benefit profile on the maternal and neonatal systems. The previously published serum and cord-blood concentration–time data of vancomycin given to mothers in the int...
Autores principales: | Farkas, Andras, Yassin, Arsheena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854597/ https://www.ncbi.nlm.nih.gov/pubmed/36671234 http://dx.doi.org/10.3390/antibiotics12010032 |
Ejemplares similares
-
1300. ACOG Committee Opinion #797 and the Dose of Intrapartum Vancomycin: a Potential Danger to Mother and Newborn Alike
por: Farkas, Andras, et al.
Publicado: (2020) -
1563. Population Pharmacokinetics and Pharmacodynamics of Daily and Extended Interval Dalbavancin Dosing Regimens for Salvage Therapy of Staphylococcus aureus Endocarditis: Mechanistic Modeling of Rabbit Infection Data to Support Human Dosing Regimens
por: Farkas, Andras, et al.
Publicado: (2019) -
1820. Indirect Standardization: A Convenient Benchmarking Approach to Antibiotic Utilization Based on Patient Mix
por: Farkas, Andras, et al.
Publicado: (2018) -
1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
por: Zhitomirsky, Sophia, et al.
Publicado: (2021) -
1564. Target Attainment of Empiric Vancomycin Therapy to Achieve Safe and Effective Exposure When it Matters Most: How Much of the Drug Do We Really Need in the First 48 Hours?
por: Yassin, Arsheena, et al.
Publicado: (2019)